Protein degrader startup Plexium raises $60M after Amgen pact endednews2025-08-28T10:44:44+00:00August 28th, 2025|Endpoints News|
Wugen collects $115M as it runs pivotal allogeneic CAR-T trialnews2025-08-27T11:00:58+00:00August 27th, 2025|Endpoints News|
AbbVie to buy psychedelic drug from partner Gilgameshnews2025-08-25T14:56:10+00:00August 25th, 2025|Endpoints News|
LB Pharmaceuticals seeks IPO as cash runs dry for looming Phase 3 schizophrenia trialnews2025-08-25T12:11:48+00:00August 25th, 2025|Endpoints News|
LB Pharmaceuticals is said to be working on IPO for schizophrenia drugnews2025-08-22T17:49:44+00:00August 22nd, 2025|Endpoints News|
Obesity drug market hits turning point after lackluster results and lull in startupsnews2025-08-22T15:28:35+00:00August 22nd, 2025|Endpoints News|
Arena BioWorks, which aims to reinvent biotech’s research model, lays off more staffnews2025-08-21T23:37:45+00:00August 21st, 2025|Endpoints News|
Cascala Health raises $8.6M to use AI in post-hospital carenews2025-08-20T11:00:45+00:00August 20th, 2025|Endpoints News|
George Church’s lab gets closer to creating human eggs in a dish, and a new startup plans to finish the jobnews2025-08-19T15:16:55+00:00August 19th, 2025|Endpoints News|
Roivant-backed VantAI and Halda line up $1B RIPTAC pactnews2025-08-19T12:00:33+00:00August 19th, 2025|Endpoints News|
